Evaluation of therapeutic effect and cytokine change during transplacental Digoxin treatment for fetal heart failure associated with fetal tachycardia, a case-control study.
Dept. of Pediatric Cardiology, West China Second University Hospital, Sichuan University, Chengdu 610041, PR China; Key Laboratory of Ob&G and Pediatric Diseases and Birth Defects of Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu 610041, PR China; Program for Yangtze River Scholars and Innovative Research Team in University, West China Medical Center, West China Second University Hospital, Sichuan University, Chengdu 610041, PR China.
Kaiyu
K
Zhou
Rong
R
Zhou
Qi
Q
Zhu
Yifei
Y
Li
Chuan
C
Wang
Chaomin
C
Wan
Dezhi
D
Mu
Yimin
Y
Hua
D000328:Adult; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage*; D015415:Biomarkers / Q000097:blood; D001805:Blood Transfusion, Intrauterine; D016022:Case-Control Studies; D016207:Cytokines / Q000097:blood*; D004077:Digoxin / Q000008:administration & dosage*; D005260:Female; D005315:Fetal Diseases / Q000097:blood / Q000188:drug therapy; D006333:Heart Failure / Q000097:blood* / Q000188:drug therapy; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D011247:Pregnancy; D013610:Tachycardia / Q000097:blood* / Q000188:drug therapy; D016896:Treatment Outcome; D055815:Young Adult
D000889:Anti-Arrhythmia Agents; D015415:Biomarkers; D016207:Cytokines; D004077:Digoxin
Cardiovascular profile score; Cytokine; Digoxin; Transplacental therapy